Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2021

18.03.2021 | Retinal Disorders

Novel retinal findings in β-thalassemia major: older age and higher ferritin level as the risk factors

verfasst von: King Hans Kurnia, Elvioza, Mohamad Sidik, Teny Tjitra Sari, Joedo Prihartono, Rita S. Sitorus

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate retinal changes in β-thalassemia major patients and identify their association with systemic risk factors.

Methods

In this prospective study, 120 β-thalassemia major patients received complete ophthalmic examinations (best-corrected visual acuity, contrast sensitivity, color vision, and indirect ophthalmoscopy) and retinal imaging using color fundus photography and fundus autofluorescence imaging. Patients were grouped according to the presence of thalassemia-related retinal changes. The association between systemic risk factors (age, type and duration of iron chelator use, history of splenectomy, hemoglobin level, and ferritin level) and thalassemia-related retinal changes was investigated using logistic regression analysis.

Results

Thalassemia-related retinal changes were identified in 36.7% of patients. Several distinct retinal changes were observed, including retinal refractile bodies in 10% of patients and retinal hemorrhage in 5.8% of patients. Fundus autofluorescence imaging showed abnormal patterns in 36.3% of patients with thalassemia-related retinal changes and 18.4% of patients without thalassemia-related retinal changes. Age (odds ratio [OR] = 1.10, 95% confidence interval [CI] 1.03–1.18) and ferritin level (OR 1.16, 95% CI 1.01–1.33) were associated with thalassemia-related retinal changes.

Conclusion

Novel retinal changes were observed in β-thalassemia major patients. This study identified older age and higher ferritin level as risk factors for thalassemia-related retinal changes.
Literatur
2.
Zurück zum Zitat Williams TN, Weatherall DJ (2012) World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2(9):a011692CrossRef Williams TN, Weatherall DJ (2012) World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2(9):a011692CrossRef
3.
Zurück zum Zitat Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D (1989) Ocular abnormalities in patients with β thalassemia. Am J Ophthalmol 108:699–703CrossRef Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D (1989) Ocular abnormalities in patients with β thalassemia. Am J Ophthalmol 108:699–703CrossRef
4.
Zurück zum Zitat Barteselli G, Dell'Arti L, Finger RP, Issa PC, Marcon A, Vezzola D, Mapelli C, Cassinerio E, Cappellini MD, Ratiglia R, Viola F (2014) The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum. Ophthalmology 121(3):709–718CrossRef Barteselli G, Dell'Arti L, Finger RP, Issa PC, Marcon A, Vezzola D, Mapelli C, Cassinerio E, Cappellini MD, Ratiglia R, Viola F (2014) The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum. Ophthalmology 121(3):709–718CrossRef
5.
Zurück zum Zitat Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P (2006) Ocular findings among thalassemia patients. Am J Ophthalmol 142(4):704–705CrossRef Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P (2006) Ocular findings among thalassemia patients. Am J Ophthalmol 142(4):704–705CrossRef
6.
Zurück zum Zitat Taneja R, Malik P, Sharma M, Agarwal MC (2010) Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol 58:125–130CrossRef Taneja R, Malik P, Sharma M, Agarwal MC (2010) Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol 58:125–130CrossRef
7.
Zurück zum Zitat Aessopos A, Savvides P, Stamatelos G, Rombos I, Tassiopoulos T, Karagiorga M, Kaklamanis P, Fessas P (1992) Pseudoxanthoma elasticum-like skin lesions and angioid streaks in β-thalassemia. Am J Hematol 41:159–164CrossRef Aessopos A, Savvides P, Stamatelos G, Rombos I, Tassiopoulos T, Karagiorga M, Kaklamanis P, Fessas P (1992) Pseudoxanthoma elasticum-like skin lesions and angioid streaks in β-thalassemia. Am J Hematol 41:159–164CrossRef
8.
Zurück zum Zitat Finger RP, Issa PC, Ladewig M, Götting C, Holz FG, Scholl HPN (2009) Fundus autofluorescence in pseudoxanthoma elasticum. Retina 29:1496–1505CrossRef Finger RP, Issa PC, Ladewig M, Götting C, Holz FG, Scholl HPN (2009) Fundus autofluorescence in pseudoxanthoma elasticum. Retina 29:1496–1505CrossRef
9.
Zurück zum Zitat Issa PC, Finger RP, Holz FG, Scholl HPN (2009) Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 50:5913–5918CrossRef Issa PC, Finger RP, Holz FG, Scholl HPN (2009) Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 50:5913–5918CrossRef
10.
Zurück zum Zitat Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG, Georgalas I (2016) β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 16(102):102CrossRef Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG, Georgalas I (2016) β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 16(102):102CrossRef
11.
Zurück zum Zitat Viola F, Barteselli G, Dell'Arti L, Vezzola D, Villani E, Mapelli C, Zanaboni L, Cappellini MD, Ratiglia R (2012) Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine. Ophthalmology 119(8):1693–1700CrossRef Viola F, Barteselli G, Dell'Arti L, Vezzola D, Villani E, Mapelli C, Zanaboni L, Cappellini MD, Ratiglia R (2012) Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine. Ophthalmology 119(8):1693–1700CrossRef
12.
Zurück zum Zitat Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S (2002) The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109:164–171CrossRef Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S (2002) The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109:164–171CrossRef
13.
Zurück zum Zitat Walia HS, Yan J (2013) Reversible retinopathy associated with oral deferasirox therapy. BMJ Case Rep 2013:bcr2013009205CrossRef Walia HS, Yan J (2013) Reversible retinopathy associated with oral deferasirox therapy. BMJ Case Rep 2013:bcr2013009205CrossRef
14.
Zurück zum Zitat Pan Y, Keane PA, Sadun AA, Fawzi AA (2010) Optical coherence tomography findings in deferasirox-related maculopathy. Retin Cases Brief Rep 4:229–232CrossRef Pan Y, Keane PA, Sadun AA, Fawzi AA (2010) Optical coherence tomography findings in deferasirox-related maculopathy. Retin Cases Brief Rep 4:229–232CrossRef
15.
Zurück zum Zitat Viola F, Barteselli G, Dell'Arti L, Vezzola D, Mapelli C, Villani E, Ratiglia R (2014) Multimodal imaging in deferoxamine retinopathy. Retina 34:1428–1438CrossRef Viola F, Barteselli G, Dell'Arti L, Vezzola D, Mapelli C, Villani E, Ratiglia R (2014) Multimodal imaging in deferoxamine retinopathy. Retina 34:1428–1438CrossRef
16.
Zurück zum Zitat Jafari R, Heydarian S, Karami H, Shektaei MM, Dailami KN, Amiri AA, Rezaee MRS, Far AAF (2015) Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol 63(9):710–715CrossRef Jafari R, Heydarian S, Karami H, Shektaei MM, Dailami KN, Amiri AA, Rezaee MRS, Far AAF (2015) Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol 63(9):710–715CrossRef
17.
18.
Zurück zum Zitat Heydarian S, Jafari R, Dailami KN, Hashemi H, Jafarzadehpour E, Heirani M, Yekta A, Mahjoob M, Khabazkhoob M (2020) Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies. Int Ophthalmol 40:511–527CrossRef Heydarian S, Jafari R, Dailami KN, Hashemi H, Jafarzadehpour E, Heirani M, Yekta A, Mahjoob M, Khabazkhoob M (2020) Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies. Int Ophthalmol 40:511–527CrossRef
19.
Zurück zum Zitat Bhoiwala DL, Dunaief JL (2016) Retinal abnormalities in β-thalassemia major. Surv Ophthalmol 61:33–50CrossRef Bhoiwala DL, Dunaief JL (2016) Retinal abnormalities in β-thalassemia major. Surv Ophthalmol 61:33–50CrossRef
20.
Zurück zum Zitat Nadim F, Walid H, Adib J (2002) The differential diagnosis of crystals in the retina. Int Ophthalmol 24:113–121CrossRef Nadim F, Walid H, Adib J (2002) The differential diagnosis of crystals in the retina. Int Ophthalmol 24:113–121CrossRef
21.
Zurück zum Zitat Habib MS, Byrne S, McCarthy JH, Steel DHW (2006) Refractile superficial retinal crystals and chronic retinal detachment: case report. BMC Ophthalmol 6:3CrossRef Habib MS, Byrne S, McCarthy JH, Steel DHW (2006) Refractile superficial retinal crystals and chronic retinal detachment: case report. BMC Ophthalmol 6:3CrossRef
22.
Zurück zum Zitat Soliman MK, Sarwar S, Hanout M, Sadiq MA, Agarwal A, Gulati V, Nguyen QD, Sepah YJ (2015) High-resolution adaptive optics findings in talc retinopathy. Int J Retina Vitreous 1:10CrossRef Soliman MK, Sarwar S, Hanout M, Sadiq MA, Agarwal A, Gulati V, Nguyen QD, Sepah YJ (2015) High-resolution adaptive optics findings in talc retinopathy. Int J Retina Vitreous 1:10CrossRef
23.
Zurück zum Zitat Ng DSC, Lai TYY, Ng TK, Pang CP (2016) Genetics of Bietti crystalline dystrophy. Asia Pac J Ophthalmol (Phila) 5(4):245–252CrossRef Ng DSC, Lai TYY, Ng TK, Pang CP (2016) Genetics of Bietti crystalline dystrophy. Asia Pac J Ophthalmol (Phila) 5(4):245–252CrossRef
24.
Zurück zum Zitat Gartaganis SP, Zoumbos N, Koliopoulos JX, Mela EK (2000) Contrast sensitivity function in patients with beta-thalassemia major. Acta Ophthalmol Scand 78:512–515CrossRef Gartaganis SP, Zoumbos N, Koliopoulos JX, Mela EK (2000) Contrast sensitivity function in patients with beta-thalassemia major. Acta Ophthalmol Scand 78:512–515CrossRef
25.
Zurück zum Zitat Yung M, Klufas MA, Sarraf D (2016) Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous 2:12CrossRef Yung M, Klufas MA, Sarraf D (2016) Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous 2:12CrossRef
26.
Zurück zum Zitat Dettoraki M, Kattamis A, Ladas I, Maragkos K, Koutsandrea C, Chatzistefanou K, Laios K, Brouzas D, Moschos MM (2017) Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients. Graefes Arch Clin Exp Ophthalmol 255(7):1349–1358CrossRef Dettoraki M, Kattamis A, Ladas I, Maragkos K, Koutsandrea C, Chatzistefanou K, Laios K, Brouzas D, Moschos MM (2017) Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients. Graefes Arch Clin Exp Ophthalmol 255(7):1349–1358CrossRef
27.
Zurück zum Zitat Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574–578CrossRef Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR (1994) Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574–578CrossRef
28.
Zurück zum Zitat Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vechhio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193PubMed Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vechhio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193PubMed
29.
Zurück zum Zitat Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF (2008) Fundus autofluorescence imaging: review and perspectives. Retina 28:385–409CrossRef Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF (2008) Fundus autofluorescence imaging: review and perspectives. Retina 28:385–409CrossRef
Metadaten
Titel
Novel retinal findings in β-thalassemia major: older age and higher ferritin level as the risk factors
verfasst von
King Hans Kurnia
Elvioza
Mohamad Sidik
Teny Tjitra Sari
Joedo Prihartono
Rita S. Sitorus
Publikationsdatum
18.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2021
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-021-05141-z

Weitere Artikel der Ausgabe 9/2021

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2021 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.